These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10810352)

  • 1. Influence of bovine calf serum on the intracellular accumulation and retention of adriamycin.
    Asaumi J; Matsuzaki H; Kawasaki S; Kuroda M; Takeda Y; Kishi K; Hiraki Y
    Anticancer Res; 2000; 20(2A):769-72. PubMed ID: 10810352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular accumulation and retention of calcein in Ehrlich ascites tumor cells and their adriamycin-resistant strain.
    Asaumi J; Kawasaki S; Kuroda M; Takeda Y; Kishi K; Hiraki Y
    Anticancer Res; 1999; 19(5B):4311-4. PubMed ID: 10628392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycin.
    Asaum J; Matsuzaki H; Kawasak S; Kuroda M; Takeda Y; Kishi K; Hiraki Y
    Anticancer Res; 2000; 20(4):2477-83. PubMed ID: 10953314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of metabolic inhibitors on the intracellular accumulation and retention of adriamycin.
    Asaumi J; Kawasaki S; Kuroda M; Takeda Y; Kishi K; Hiraki Y
    Anticancer Res; 1999; 19(1A):615-8. PubMed ID: 10226607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 completely inhibits adriamycin efflux in the adriamycin-resistant strain of Ehrlich ascites tumor cells.
    Asaumi J; Kawasaki S; Nishikawa K; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1996; 16(1):247-50. PubMed ID: 8615615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermosensitivity and thermotolerance in the adriamycin-resistant strain of Ehrlich ascites tumor cells.
    Asaumi J; Kawasaki S; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1996; 16(5A):2569-73. PubMed ID: 8917353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cepharanthin and hyperthermia on the intracellular accumulation of adriamycin and Fluo3, an indicator of Ca2+.
    Nishikawa K; Asaumi J; Kawasaki S; Shibuya K; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1998; 18(3A):1649-54. PubMed ID: 9673384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cepharanthin and hyperthermia on the intracellular accumulation of adriamycin in the NIH3T3 cell lines transfected with oncogenes accompanied with pSV2neo vector.
    Gaoi XS; Asaumi J; Kawasaki S; Nishikawa K; Kuroda M; Li H; Takeda Y; Hiraki Y; Ihara M; Ohnishi T
    Anticancer Res; 1995; 15(5B):1991-6. PubMed ID: 8572590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells.
    Miccadei S; Fanciulli M; Bruno T; Paggi MG; Floridi A
    Oncol Res; 1996; 8(1):27-35. PubMed ID: 8704284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hyperthermia and cepharanthin on adriamycin accumulation with changes in extracellular pH.
    Asaumi J; Kawasaki S; Nishikawa K; Kuroda M; Hiraki Y
    Int J Hyperthermia; 1995; 11(1):27-35. PubMed ID: 7714368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cepharanthin on the intracellular accumulation of adriamycin in normal liver cells and spleen cells of mice in vitro and in vivo.
    Nishikawa K; Asaumi J; Kawasaki S; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1997; 17(5A):3617-21. PubMed ID: 9413213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR.
    Katsui K; Kuroda M; Wang Y; Komatsu M; Himei K; Takemoto M; Akaki S; Asaumi J; Kanazawa S; Hiraki Y
    Int J Oncol; 2004 Jul; 25(1):47-56. PubMed ID: 15201988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B
    Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells.
    Astier A; Doat B; Ferrer MJ; Benoit G; Fleury J; Rolland A; Leverge R
    Cancer Res; 1988 Apr; 48(7):1835-41. PubMed ID: 2894892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562/A02 cells.
    Cui X; Zhou S; Xu H; Zhao T; Liu A; Guo X; Wang F
    Anticancer Drugs; 2009 Oct; 20(9):800-6. PubMed ID: 19606017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
    Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
    Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of extracellular ion concentration on the intracellular accumulation of adriamycin.
    Nishikawa K; Asaumi J; Kawasaki S; Shibuya K; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1998; 18(2A):915-8. PubMed ID: 9615741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S; Dutta P; Mookerjee A; Choudhuri SK
    Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.